Verapamil inhibits proliferation, migration and protein kinase C activity in human retinal pigment epithelial cells

Experimental Eye Research

Volumn 67, Issue 1, 1998, Pages 45-52

  Hoffman, Stephan ^a   Gopalakrishna, Rayudu ^a   Gundimeda, Usha ^a   Murata, Toshinori ^a   Spee, Christine ^a   Ryan, Stephen J ^a   Hinton, David R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Calcium channel antagonists; Migration; PKC; Proliferation; RPE; Verapamil

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; MITOMYCIN C; NIFEDIPINE; PROTEIN KINASE C; TRYPAN BLUE; VERAPAMIL;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; FETUS; HUMAN; HUMAN CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; VITREORETINOPATHY;

EID: 0032128446     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.1998.0491     Document Type: Article

References (52)

1. 45. Prostate. 19:1991;299-311.
2. Baudouin C., Fredj-Reygrobellet D., Brignole F., Négre F., Lapulus P., Gastaud P. Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy. Ophthalmic Res. 25:1993;52-59.
3. Baudouin C., Fredj-Reygrobellet D., Baudouin F., Lapulus P., Gastaud P. Immunohistologic study of proliferative vitreoretinopathy. Am. J. Ophthalmol. 108:1989;387-394.
4. Berridge M. J. Inositol trisphosphate and calcium signalling. Nature. 361:1993;315-325.
5. Bertrand V., Bastié M. J., Vaysse N., Pradayrol L. Inhibition of gastrin-induced proliferation of AR4-2J cells by calcium channel antagonists. Int. J. Cancer. 56:1994;427-432.
6. Blumenkranz M. S., Hartzer M. K. The mechanism of action of drugs for the treatment of vitreoretinal scarring. Retina. 1994;Mosby. p. 2281-93.
7. 2+2+. Eur. J. Pharmacol. 247:1993;325-331.
8. Catterall W. A., Seagar M. J., Takahashi M. Molecular properties of dihydropyridine-sensitive calcium channels in skeletal muscle. J. Biol. Chem. 263:1988;3535-3538.
9. Charteris D. G. Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br. J. Ophthalmol. 79:1995;953-960.
10. Cole K., Kohn E. Calcium-mediated signal transduction: biology, biochemistry, and therapy. Cancer Metastasis Rev. 13:1994;31-44.
11. Durham A. C., Walton J. M. Calcium ions and the control of proliferation in normal and cancer cells. Biosci. Rep. 2:1982;15-30.
12. Fine R. L., Koizumi S., Curt G. A., Chabner B. A. Effect of calcium channel blockers on human CFU-GM with cytotoxic drugs. J. Clin. Oncol. 5:1987;489-495.
13. Freshny R. I. Animal cell culture: a practical approach. 1992;IRL Press.
14. Frishman W., Kirsten E., Klein M., Pine M., Johnson S. M., Hillis L. D., Packer M., Kates R. Clinical relevance of verapamil plasma levels in stable angina pectoris. Am. J. Cardiol. 50:1982;1180-1184.
15. Gabrielian K., Gopalakrishna R., Gundimeda U., Kohen L., Ryan S. J., Hinton D. R. Protein kinase C activity and isozyme profile in cultured RPE cells. ARVO abstract. Invest. Ophthalmol. Vis. Sci. 35:1994;1756.
16. Glaser B. M., Lemor M. Pathobiology of proliferative vitreoretinopathy. Ryan S. J. Retina. 1994;2249-2263 Mosby.
17. Glossmann H., Striessnig J. Calcium channels. Vitam. Horm. 44:1988;155-328.
18. Goodman G. E., Yen Y. P., Cox T. C., Crowley J. Effect of verapamil on in vitro cytotoxicity of adriamycin and vinblastine in human tumor cells. Cancer Res. 47:1987;2295-2304.
19. Gopalakrishna R., Anderson B. A. Reversible oxidative activation and inactivation of protein kinase C by the mitogen/tumor promoter periodate. Arch. Biochem. Biophys. 285:1991;382-387.
20. Gopalakrishna R., Chen Z. H., Gundimeda U. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J. Biol. Chem. 268:1993;27180-27185.
21. Gopalakrishna R., Chen Z. H., Gundimeda U., Wilson J. C., Anderson W. B. Rapid filtration assays for protein kinase C activity and phorbol ester binding using multiwell plates with fitted filtration discs. Anal. Biochem. 206:1992;24-35.
22. Hahn J. M., Lyon A. T., Weinberg D. U., Krupin T. Calcium channel blocker mediated inhibition of retinal pigment epithelial cell contraction of collagen gels. ARVO abstract. Invest. Ophthalmol. Vis. Sci. 37:1996;S393.
23. Harris M. S., Sakamoto T., Kimura H., He S., Spee C., Gopalakrishna R., Gundimeda U., Yoo J. S., Hinton D. R., Ryan S. J. Hypericin inhibits cell growth and induces apopotosis in retinal pigment epithelial cells: possible involvement of protein kinase C. Curr. Eye Res. 15:1996;255-262.
24. Hinton D. R., He S., Graf K., Yang D. C., Ryan S. J., Law R. E. Migration of RPE cells induced by PDGF and fibronectin is mediated through MAP kinase signaling pathway. Exp. Cell Res. 239:1998;11-15.
25. Hofer C. A., Smith J. K., Tenholder M.-F. Verapamil intoxication: a literature review of overdoses and discussion of therapeutic options. Am. J. Med. 95:1993;431-438.
26. Jensen R. L., Lee Y. S., Guijrati M., Origitano T. C., Wurster R. D., Reichman O. H. Inhibition of in vitro meningioma proliferation after growth factor stimulation by calcium channel antagonists: Part II - Additional growth factors, growth factor receptor immunohistochemistry, and intracellular calcium measurements. Neurosurgery. 37:1995;937-946.
27. Jensen R.-L., Origitano T. C., Lee Y. S., Weber M., Wurster R. D. In vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists. Neurosurgery. 36:1995;365-373.
28. Kaneko T., Nagata I., Miyamoto S., Kubo H., Kikuchi H., Fujisato T., Ikada Y. Effects of nicardipine on tube formation of bovine vascular endothelial cells in vitro. Stroke. 23:1992;1637-1642.
29. 2+2+. Pharmacology. 37:1988;917-920.
30. 2+2+. Mol. Chem. Neuropathol. 22:1994;81-95.
31. Limb G. A., Little B. C., Meager A., Ogilvie J. A., Wolstencroft R. A., Franks W. A., Chignell A. H., Dumonde D. C. Cytokines in proliferative vitreoretinopathy. Eye. 5:1991;686-693.
32. Mori T., Takai Y., Minakuchi R., Yu B., Niskizuka Y. Inhibitory action of chlorpromazine, dibucaine, and other phospholipid-interacting drugs on calcium-activated, phospholipid-dependent protein kinase. J. Biol. Chem. 255:1980;8378-8380.
33. Murphy T. L., Sakamoto T., Hinton D. R., Spee C., Gundimeda U., Soriano D., Gopalakrishna R., Ryan S. J. Migration of retinal pigment epithelium cells in vitro is regulated by protein kinase C. Exp. Eye Res. 60:1995;683-695.
34. Orlidge A., D'Amore P. A. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J. Cell Biol. 105:1987;1455-1462.
35. Pepper M. S., Vassalli J. D., Montesano R., Orci L. Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J. Cell Biol. 105:1987;2535-2541.
36. Pülhorn G., Teichmann K. D., Teichmann I. Intraocular fibrous proliferation as an incisional complication in pars plana vitrectomy. Am. J. Ophthalmol. 83:1977;810-814.
37. Rasmussen H., Barrett P. Q. Calcium messenger system: an integrated view. Physiol. Rev. 64:1984;938-984.
38. Reiter M. J., Shand D. G., Aanonsen L. M., Wagoner R., McCarthy E., Pritchett E. L. Pharmacokinetics of verapamil: experience with a sustained intravenous infusion regimen. Am. J. Cardiol. 50:1982;716-721.
39. Richter D., Hatvani I., Tóth A. Wachstumshemmung intraokularer proliferativer Explantate unter in-vitro-Bedingungen durch Verapamil. Klin. Monatsbl. Augenheilkd. 203:1993;206-211.
40. Ryan S. J. The pathophysiology of proliferative vitreoretinopathy in its management. Am. J. Ophthalmol. 100:1985;188-193.
41. Schmidt W. F., Huber K. R., Ettinger R. S., Newberg R. W. Antiproliferative effect of verapamil alone on brain tumor cells in vitro. Cancer Res. 48:1988;3617-3621.
42. Spedding M., Paoletti R. Classification of calcium channels and the sites of action of drugs modifying channel function. Pharmacol. Rev. 44:1992;363-376.
43. Stalmans P., Himpens B. Confocal imaging of Ca singaling in cultured rat retinal pigment epithelial cells during mechanical and pharmacological stimulation. Invest. Ophthalmol. Vis. Sci. 38:1997;176-187.
44. Steinleitner A., Lambert H., Kazensky B. S., Sanchez I., Sueldo C. Reduction of primary postoperative adhesion formation under calcium channel blockade in the rabbit. J. Surg. Res. 48:1990;42-45.
45. Taylor J. M., Simpson R. U. Inhibition of cancer cell growth by calcium channel antagonists in the athymic mouse. Cancer Res. 52:1992;2413-2418.
46. Ueda Y., Steinberg R. H. Dihydropyridine-sensitive calcium currents in freshly isolated human and monkey retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 36:1995;373-380.
47. Wagner M., Benson M. T., Rennie I. G., MacNeil S. Effects of pharmacological modulation of intracellular signalling systems on retinal pigment cell attachment to extracellular matrix proteins. Curr. Eye Res. 14:1995;374-384.
48. Whitaker M. Regulation of the cell division cycle by inositol trisphosphate and the calcium signaling pathway. Adv. Second Messenger Phosphoprotein Res. 30:1995;299-310.
49. Wiedemann P. Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. Surv. Ophthalmol. 36:1992;373-384.
50. Wiedemann P., Weller M. The pathophysiology of proliferative vitreoretinopathy. Acta Ophthalmol. Suppl. 189:1988;3-15.
51. 2+. Trends Pharmacol. Sci. 11:1990;38-44.
52. Zhu Y. L., Zhu Y. J., Guo A. J., Zhao W. L., Liu B. C. Effects of calcium and calmodulin inhibitors on the abnormal proliferation of lung fibroblast. Chin. Med. J. 107:1994;487-490.